Latest Breaking News On - Amandai adler - Page 1 : comparemela.com

Early Glycaemic Control in T2D Produces Long-Term Benefit

Data from the landmark UK Prospective Diabetes Study showed cardiovascular and survival benefits of intensive glycaemic control at 24 years.

United kingdomAmandai adlerUniversity of oxfordNational health serviceRadcliffe department of medicineUnited kingdom prospective diabetes studyDiabetes trials unitRadcliffe departmentOxford nuffield departmentPopulation health pump

Early blood glucose control for those with type 2 diabetes crucial for reducing complications, prolonging life

Research led by scientists from the Universities of Oxford and Edinburgh has found that early good blood glucose control can minimize the lifetime risk of diabetes-related complications, including heart attacks, kidney failure and vision loss.

Rury holmanAmanda adlerAmandai adlerPhilip clarkeClinical brain sciencesUniversity of oxford health economics research centerUniversity of edinburgh centerJapan diabetes societyData science centerOxford radcliffe department of medicineUniversity of oxford diabetes trials unitUnited kingdom prospective diabetes studyRadcliffe departmentOxford diabetes trials unitChief investigatorDiabetes trial unit

Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data

Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data
bmj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bmj.com Daily Mail and Mail on Sunday newspapers.

United kingdomStephen oneillPaul charltonJonathanw bartlettDaiichi sankyoRahul mohanDavidg lugo palaciosRichard grieveKen patersonDorothea nitschEwan pearsonRichardj silverwoodJim lewseyAnirban basuKamlesh khuntiStephen evans

AMPLITUDE-O: Efpeglenatide Benefits in High-Risk Diabetes

AMPLITUDE-O: Efpeglenatide Benefits in High-Risk Diabetes
medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomAmandai adlerZuellig pharmaHertzelc gersteinEli lillyNaveed sattarMcmaster universityUniversity of oxfordBoehringer ingelheimAmerican diabetes associationUniversity of glasgowNovo nordiskHanmi pharmaceuticalNew england journalImportant findings